Israeli start-up Alcobra set out to develop a pill that would reduce blood alcohol but came up with a treatment for Attention Deficit Disorder. Alcobra claims metadoxine has all the benefits of Ritalin, Concerta, and Strattera without their drawbacks.
http://www.algemeiner.com/2013/12/02/israeli-start-up-alcobra-develops-new-treatment-for-attention-deficit-disorder/
New treatment for ADD
This entry was posted in Israel's Medical Achievements. Bookmark the permalink.